IN2013MU03310A - - Google Patents

Info

Publication number
IN2013MU03310A
IN2013MU03310A IN3310MU2013A IN2013MU03310A IN 2013MU03310 A IN2013MU03310 A IN 2013MU03310A IN 3310MU2013 A IN3310MU2013 A IN 3310MU2013A IN 2013MU03310 A IN2013MU03310 A IN 2013MU03310A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
sulbactam
imipenem
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Swapna Shripad Takalkar
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3310MU2013 priority Critical patent/IN2013MU03310A/en
Priority to PCT/IB2014/065496 priority patent/WO2015059629A1/fr
Priority to EP14802501.8A priority patent/EP3060212A1/fr
Priority to US15/030,005 priority patent/US20160310472A1/en
Publication of IN2013MU03310A publication Critical patent/IN2013MU03310A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IN3310MU2013 2013-10-22 2014-10-21 IN2013MU03310A (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN3310MU2013 IN2013MU03310A (fr) 2013-10-22 2014-10-21
PCT/IB2014/065496 WO2015059629A1 (fr) 2013-10-22 2014-10-21 Compositions pharmaceutiques comprenant le sulbactam et l'imipenem
EP14802501.8A EP3060212A1 (fr) 2013-10-22 2014-10-21 Compositions pharmaceutiques comprenant le sulbactam et l'imipenem
US15/030,005 US20160310472A1 (en) 2013-10-22 2014-10-21 Pharmaceutical compositions comprising sulbactam and imipenem

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3310MU2013 IN2013MU03310A (fr) 2013-10-22 2014-10-21

Publications (1)

Publication Number Publication Date
IN2013MU03310A true IN2013MU03310A (fr) 2015-07-31

Family

ID=51947405

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3310MU2013 IN2013MU03310A (fr) 2013-10-22 2014-10-21

Country Status (4)

Country Link
US (1) US20160310472A1 (fr)
EP (1) EP3060212A1 (fr)
IN (1) IN2013MU03310A (fr)
WO (1) WO2015059629A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129382B (zh) * 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方
FR2955028B1 (fr) * 2010-01-13 2012-03-02 Centre Nat Rech Scient Traitement des infections par les chlamydiaceae par les beta-lactames
CN102349896B (zh) * 2011-07-22 2013-03-27 广州定慧医药科技有限公司 一种亚胺培南西司他丁舒巴坦的药物组合物
RU2569059C2 (ru) * 2011-07-26 2015-11-20 Вокхардт Лимитед Фармацевтические композиции, содержащие бета-лактамный антибиотик, сульбактам и ингибитор бета-лактамаз

Also Published As

Publication number Publication date
EP3060212A1 (fr) 2016-08-31
US20160310472A1 (en) 2016-10-27
WO2015059629A1 (fr) 2015-04-30

Similar Documents

Publication Publication Date Title
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
EP3082817A4 (fr) Compositions pour administration de médicaments
EP3129048A4 (fr) Anticorps, compositions pharmaceutiques et leurs utilisations
IL243627A0 (en) Pharmaceutical preparations of pancreatin with high potency
TW201144301A (en) Processes for preparing linezolid
IL284419A (en) Pharmaceutical preparations of pancreatin with high potency
EP3731832A4 (fr) Forme posologique à base de cannabinoïdes
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
EP3048103A4 (fr) Composé immunomodulateur, son utilisation et composition pharmaceutique comprenant ce composé
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
IN2013MU01985A (fr)
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
EP3190129A4 (fr) Dérivé de peptide à action centrale, et composition pharmaceutique
HK1213810A1 (zh) 施用和相關的組合物、方法和系統
IL238851A0 (en) The history of pyrrolidine, pharmaceutical preparations and their uses
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
PH12017500071A1 (en) Therapeutic agent for keratoconjunctive disorder
IN2013MU03422A (fr)
IN2014MU00859A (fr)
IN2013MU03310A (fr)
GEP20196989B (en) Pharmaceutical composition comprising bisoprolol and perindoril
IN2013MU02015A (fr)
EP3206683A4 (fr) Nouveaux procédés, composés et compositions d'anesthésie